Cases and Deals
Deal

iCad Inc. in a $30 Million Follow-on Public Offering

Blank Rome represented iCAD Inc. (NASDAQ: ICAD), a Nasdaq-traded public company that provides advanced image analysis and radiation therapy for the early identification and treatment of cancer, in a $30 million follow-on public offering of common stock. The transaction closed on March 17, 2014.